Metaxalone
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
Metaxalone
|
|
| Systematic (IUPAC) name | |
| 5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C12H15NO3 |
| Mol. mass | 221.252 g/mol |
| Pharmacokinetic data | |
| Bioavailability | Unknown |
| Metabolism | Hepatic |
| Half life | 9.2 (± 4.8) hours |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
C(US) |
| Legal status | |
| Routes | Oral |
Metaxalone (marketed by King Pharmaceuticals under the brand name Skelaxin®) is a muscle relaxant used to relax muscles and relieve pain caused by strains, sprains, and other musculoskeletal conditions. It is considered to be a moderately strong muscle relaxant. Skelaxin comes in an 800 mg scored tablet. It previously came in both 400 mg and 800 mg tablets. The 400 mg tablet has been discontinued.
[edit] External links
- Skelaxin (manufacturer's website)
- Skelaxin Product Information Provided by King
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
